Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Xu, Lei  [Clear All Filters]
Journal Article
Xu J, Shao Z, Jia S, Sha J, Li J, Gao F, Shi X, Wang J, Jin C, Jiang M, et al. A comprehensive stem cell laboratory module with blended learning for medical students at Tongji University. Biochem Mol Biol Educ. 2024.
Xu L, Wang J, Liu Y, Xie L, Su B, Mou D, Wang L, Liu T, Wang X, Zhang B, et al. CRISPR-Edited Stem Cells in a Patient with HIV and Acute Lymphocytic Leukemia. N Engl J Med. 2019.
Wang S, Dong J, Li L, Wu R, Xu L, Ren Y, Hu X. Exosomes derived from miR-129-5p modified bone marrow mesenchymal stem cells represses ventricular remolding of mice with myocardial infarction. J Tissue Eng Regen Med. 2021.
Xu L, Zeng Q, Liang L, Yang Z, Qu M, Li H, Zhang B, Zhang J, Yuan X, Chen L, et al. Generation of Rh D-negative blood using CRISPR/Cas9. Cell Prolif. 2023:e13486.
Xu L, Willumeit-Römer R, Luthringer-Feyerabend B. Hypoxia influences the effects of magnesium degradation products on the interactions between endothelial and mesenchymal stem cells. Acta Biomater. 2019.
Yang J, Zhang X, Lu B, Mei J, Xu L, Zhang X, Su Z, Xu W, Fang S, Zhu C, et al. Inflammation-Responsive Hydrogel Spray for Synergistic Prevention of Traumatic Heterotopic Ossification via Dual-Homeostatic Modulation Strategy. Adv Sci (Weinh). 2023:e2302905.
Zhu W, Xu L, Li X, Hu H, Lou S, Liu Y. iPSCs-Derived Neurons and Brain Organoids from Patients. Handb Exp Pharmacol. 2023.
Gao Y, Wang F, Zhang L, Kang M, Zhu L, Xu L, Liang W, Zhang W. LINC00311 promotes cancer stem-like properties by targeting miR-330-5p/TLR4 pathway in human papillary thyroid cancer. Cancer Med. 2020.
Liang L, Xu L, Dong Q, Zhang J, Qu M, Yuan X, Zeng Q, Li H, Zhang B, Wang C, et al. Low initial cell density promotes the differentiation and maturation of human pluripotent stem cells into erythrocytes. Stem Cells Dev. 2024.
Wang Q, Xu L, Willumeit-Römer R, Luthringer-Feyerabend BJC. Macrophage-derived oncostatin M/bone morphogenetic protein 6 in response to Mg-based materials influences pro-osteogenic activity of human umbilical cord perivascular cells. Acta Biomater. 2020.
Yin Y, Bijvelds M, Dang W, Xu L, van der Eijk AA, Knipping K, Tüysüz N, Dekkers JF, Wang Y, de Jonge J, et al. Modeling rotavirus infection and antiviral therapy using primary intestinal organoids. Antiviral Res. 2015.
Sotelo JR, Canclini L, Kun A, Sotelo-Silveira JR, Xu L, Wallrabe H, Calliari A, Rosso G, Cal K, Mercer JA. Myosin-va-dependent cell-to-cell transfer of RNA from schwann cells to axons. PLoS One. 2013;8(4):e61905.
Wang Z, Wang Q, Chen C, Zhao X, Wang H, Xu L, Fu Y, Huang G, Li M, Xu J, et al. NNMT enriches for AQP5 cancer stem cells to drive malignant progression in early gastric cardia adenocarcinoma. Gut. 2023.
Tang X-Y, Xu L, Wang J, Hong Y, Wang Y, Zhu Q, Wang D, Zhang X-Y, Liu C-Y, Fang K-H, et al. Suppressing the DSCAM/PAK1 pathway reverses neurogenesis deficits in Down Syndrome patient iPSC-derived cerebral organoids. J Clin Invest. 2021.
Qu Z, Guan Y, Cui L, Song J, Gu J, Zhao H, Xu L, Lu L, Jin Y, Xu G-T. Transplantation of rat embryonic stem cell-derived retinal progenitor cells preserves the retinal structure and function in rat retinal degeneration. Stem Cell Res Ther. 2015;6:219.
Zhang R, Chen H, Zheng Z, Liu Q, Xu L. Umbilical cord-derived mesenchymal stem cell therapy for neurological disorders via inhibition of mitogen-activated protein kinase pathway-mediated apoptosis. Mol Med Rep. 2014.